Teladoc Health (NYSE:TDOC) Shares Gap Up - Should You Buy?

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) shares gapped up before the market opened on Friday . The stock had previously closed at $8.96, but opened at $9.66. Teladoc Health shares last traded at $8.93, with a volume of 1,243,467 shares changing hands.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on TDOC. Deutsche Bank Aktiengesellschaft increased their price target on Teladoc Health from $10.00 to $12.00 and gave the company a "hold" rating in a research report on Friday, November 1st. JPMorgan Chase & Co. lowered their target price on shares of Teladoc Health from $16.00 to $9.00 and set a "neutral" rating on the stock in a report on Monday, August 26th. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a research note on Thursday, August 1st. TD Cowen cut their target price on Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research note on Thursday, October 31st. Finally, Oppenheimer reduced their target price on Teladoc Health from $21.00 to $17.00 and set an "outperform" rating for the company in a report on Thursday, August 1st. Fourteen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $12.08.

Teladoc Health Trading Up 2.6 %

The stock's fifty day moving average price is $8.89 and its two-hundred day moving average price is $9.41. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $1.58 billion, a P/E ratio of -1.59 and a beta of 0.90.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.51 million during the quarter, compared to analyst estimates of $630.50 million. Equities research analysts forecast that Teladoc Health, Inc. will post -1.19 EPS for the current year.

Insider Buying and Selling at Teladoc Health

In other news, COO Michael Willem Waters sold 4,218 shares of the business's stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $30,200.88. Following the sale, the chief operating officer now owns 78,309 shares in the company, valued at approximately $560,692.44. The trade was a 5.11 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Thomas Mckinley bought 4,000 shares of Teladoc Health stock in a transaction dated Thursday, September 12th. The stock was acquired at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the transaction, the director now directly owns 39,077 shares in the company, valued at approximately $300,502.13. This trade represents a 11.40 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold 20,051 shares of company stock valued at $143,565 in the last 90 days. Insiders own 0.95% of the company's stock.

Hedge Funds Weigh In On Teladoc Health

Several large investors have recently modified their holdings of TDOC. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Teladoc Health by 2.1% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 65,588 shares of the health services provider's stock valued at $641,000 after buying an additional 1,352 shares during the last quarter. Covestor Ltd increased its position in Teladoc Health by 58.1% during the first quarter. Covestor Ltd now owns 3,817 shares of the health services provider's stock valued at $57,000 after acquiring an additional 1,403 shares during the last quarter. Signaturefd LLC lifted its holdings in Teladoc Health by 148.7% in the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider's stock valued at $28,000 after acquiring an additional 1,715 shares during the period. Swiss National Bank boosted its position in Teladoc Health by 0.6% in the first quarter. Swiss National Bank now owns 326,902 shares of the health services provider's stock worth $4,936,000 after purchasing an additional 1,800 shares during the last quarter. Finally, Blue Trust Inc. grew its stake in shares of Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider's stock valued at $40,000 after purchasing an additional 1,854 shares during the period. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.